DOCSLIB.ORG

Cancer Treatment Reviews

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Cancer Treatment Reviews CANCER TREATMENT REVIEWS AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Impact Factor p.1 • Abstracting and Indexing p.1 • Editorial Board p.1 • Guide for Authors p.4 ISSN: 0305-7372 DESCRIPTION . Cancer Treatment Reviews is an international journal that provides state of the art, authoritative review articles to the clinician and researcher to keep them abreast of modern concepts and the latest developments in cancer treatment research. Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services. Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center IMPACT FACTOR . 2020: 12.111 © Clarivate Analytics Journal Citation Reports 2021 ABSTRACTING AND INDEXING . Scopus PubMed/Medline Current Contents - Clinical Medicine Science Citation Index Index to Scientific Reviews Research Alert Medical Documentation Service SIIC Data Bases EDITORIAL BOARD . Editors A Cervantes, University of Valencia, Biomedical Research Institute, Inclivia, Department of Hematology and Medical Oncology, Valencia, Spain AUTHOR INFORMATION PACK 30 Sep 2021 www.elsevier.com/locate/ctrv 1 Neurology G. Curigliano, European Institute of Oncology, Milan, Italy breast cancer G. Lenz, University Hospital Munster, Munster, Germany molecular pathogenesis of aggressive lymphoma, NF-κB pathway, PI3K/AKT signalling, tumour microenvironment R.A. Stahel, University of Zurich, Zurich, Switzerland lung and thoracic oncology Editorial Board S Aebi, Luzern, Switzerland breast cancer and gynecological tumors S. Banerjee, London, United Kingdom Gynaecological cancers, ovarian, endometrial, cervical cancers, PARP inhibitors D. Bedognetti, Doha, Qatar Tumor Biology Immunology J. Bellmunt, Barcelona, Spain Solid Tumor Oncology (GU & GI) S Bielack, Stuttgart, Germany pediatric oncology, adolescents and young adults with cancer, bone sarcoma J. Bruix, Barcelona, Spain hepatocellular carcinoma, intrahepatic chilangiocarcinoma, diagnosis and treatment R. Califano, Manchester, United Kingdom small cell lung cancer and non small cell lung cancer , egfr , alk and immunotherapy F. Cardoso, Lisboa, Portugal biology of breast cancer, prognostic and predictive markers of response to systemic therapy, and new anticancer agents P. Casali, Milano, Italy adult sarcomas, including gastrointestinal stromal tumours A. Chan, Sydney, Australia Head and neck cancers , Nasopharynx cancer, Epstein Barr Virus R.C. Coleman, Sheffield, United Kingdom Cancer, Bone, Biomarkers, Bisphosphonates, Clinical trials D. De Ruysscher, Maastricht, Netherlands radiation oncology C. Dittrich, Wien, Austria Methodology of clinical trials, Clinical trial regulation, Pancreatic cancer R. Dziadziuszko, Gdansk, Poland T. Eisen, Cambridge, United Kingdom Renal cell carcinoma, Drug development M. Hutchings, Copenhagen, Denmark lymphoma K Jordan, Heidelberg, Germany Internal Medicine and Haematology and Oncology M. Ladetto Hemato-Oncology F. Lordick, Leipzig, Germany hematology and oncology R.J. Mayer, Boston, Massachusetts, United States of America hematology and oncology O Michielin, Lausanne, Switzerland translational oncology C. Pezaro, Melbourne, Australia Genitourinary cancer, Prostate cancer, Clinical research, Translational research. M.R. Posner, New York, New York, United States of America Hematology-Oncology, Cancer (Oncology) A. Prat, Barcelona, Spain breast cancer -omics, and clinical implementation of omic-based assays. Specialties: Breast Cancer Gene Expression Profiling M. Preusser, Wein, Austria characterization of inflammatory infiltrates and immune checkpoint molecules in cancer, anti-cancer drugs including immunotherapies S.A. Quezada, London, United Kingdom AUTHOR INFORMATION PACK 30 Sep 2021 www.elsevier.com/locate/ctrv 2 Immune Regulation and Tumour Immunotherapy C. Sessa, Bern, Switzerland Obstetrics and Gynaecology, Pharmacology J. Tabernero, Barcelona, Spain colorectal cancer K. Tamura Breast and Medical Oncology P Tan, Singapore, Singapore gastric cancer M. Weller, Zurich, Switzerland brain tumors and the diagnosis and therapy of glioblastoma and other primary brain tumors. Y.L. Wu, Guangzhou, China Multidisciplinary therapy and translational medicine on lung cancer, Evidence-based medicine in Oncology AUTHOR INFORMATION PACK 30 Sep 2021 www.elsevier.com/locate/ctrv 3 GUIDE FOR AUTHORS . Aims and scope Cancer Treatment Reviews is an international review journal that will keep both the clinician and researcher abreast of modern concepts and developments in cancer treatment research through the publication of state of the art, authoritative reviews; evidence-based reviews (using a priori defined selection process to identify key articles from the literature and reviewing them in the form of a structured abstract, evidence summary and commentary); and systematic reviews. Please note that the journal will not accept original articles (including meta analyses). Types of contribution Authors will be asked to assign their contribution to one of the following areas: • Comments on Controversy • Tumour Review • Anti-tumour Treatment • New Drugs • Complications of Treatment • General and Supportive Care • Laboratory-Clinic Interface • Systematic or Meta-analysis Studies The journal has a limit of 5000 words (excluding any tables or figures) and 6 figures and/or tables for each review article. A maximum of 100 references is recommended although exceptions can be made subject to the approval of the Editors. Submission checklist You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details. Ensure that the following items are present: One author has been designated as the corresponding author with contact details: • E-mail address • Full postal address All necessary files have been uploaded: Manuscript: • Include keywords • All figures (include relevant captions) • All tables (including titles, description, footnotes) • Ensure all figure and table citations in the text match the files provided • Indicate clearly if color should be used for any figures in print Graphical Abstracts / Highlights files (where applicable) Supplemental files (where applicable) Further considerations • Manuscript has been 'spell checked' and 'grammar checked' • All references mentioned in the Reference List are cited in the text, and vice versa • Permission has been obtained for use of copyrighted material from other sources (including the Internet) • A competing interests statement is provided, even if the authors have no competing interests to declare • Journal policies detailed in this guide have been reviewed • Referee suggestions and contact details provided, based on journal requirements For further information, visit our Support Center. BEFORE YOU BEGIN Ethics in publishing Please see our information on Ethics in publishing. AUTHOR INFORMATION PACK 30 Sep 2021 www.elsevier.com/locate/ctrv 4 Studies in humans and animals If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. The manuscript should be in line with the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals and aim for the inclusion of representative human populations (sex, age and ethnicity) as per those recommendations. The terms sex and gender should be used correctly. Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed. All animal experiments should comply with the ARRIVE guidelines and should be carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU for animal experiments, or the National Institutes of Health guide for the care and use of Laboratory animals (NIH Publications No. 8023, revised 1978) and the authors should clearly indicate in the manuscript that such guidelines have been followed. The sex of animals must be indicated, and where appropriate, the influence (or association) of sex on the results of the study. Informed consent and patient details Studies on patients or volunteers require ethics committee approval and informed consent, which should be documented in the paper. Appropriate consents, permissions and releases must be obtained where an author wishes to include case details or other personal information or images of patients and any other individuals in an Elsevier publication. Written consents must be retained by the author but copies should not be provided to the journal. Only if specifically requested by the journal in exceptional circumstances (for example if a legal issue arises) the author must provide copies of the consents or evidence that such consents have been obtained. For more information, please review the Elsevier Policy on the Use of Images or Personal Information of Patients or other Individuals. Unless you have written permission from the patient (or, where applicable, the next of kin), the personal details of any patient included in any part of the article and
Load more

Recommended publications
  • A Comparative Study of Negative Citations and Post-Publication Peer Review Frédérique Bordignon
    Self-correction of science: a comparative study of negative citations and post-publication peer review Frédérique Bordignon To cite this version: Frédérique Bordignon. Self-correction of science: a comparative study of negative citations and post-publication peer review. Scientometrics, Springer Verlag, 2020, 124 (2), pp.1225-1239. 10.1007/s11192-020-03536-z. hal-02778897 HAL Id: hal-02778897 https://hal-enpc.archives-ouvertes.fr/hal-02778897 Submitted on 4 Jun 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution| 4.0 International License Self-correction of science: a comparative study of negative citations and post-publication peer review Frederique Bordignon Ecole des Ponts, Marne-la-Vallée, France [email protected] 0000-0002-4918-9137 Abstract This study investigates whether negative citations in articles and comments posted on post-publication peer review platforms are both equally contributing to the correction of science. These 2 types of written evidence of disputes are compared by analyzing their occurrence in relation to articles that have already been retracted or corrected. We identified retracted or corrected articles in a corpus of 72,069 articles coming from the Engineering field, from 3 journals (Science, Tumor Biology, Cancer Research) and from 3 authors with many retractions to their credit (Sarkar, Schön, Voinnet).
    [Show full text]
  • Print Special Issue Flyer
    IMPACT FACTOR 6.639 an Open Access Journal by MDPI Biomarkers in Interventional Oncology Guest Editors: Message from the Guest Editors Dr. Marianna Alunni-Fabbroni Targeted minimally invasive procedures are being Department of Radiology, increasingly used in multimodality concepts of University Hospital, LMU Munich, personalized cancer treatment. Interventional oncology 81377 München, Germany applies thermal energy, radiation, or local delivery of marianna.alunni@ med.uni- muenchen.de chemotherapeutic agents at a high dosage directly into the tumor under image guidance in order to treat cancer more Prof. Dr. Moritz Wildgruber effectively. Interventional oncology plays an increasing role Department of Radiology, and is now considered the fourth pillar of oncology University Hospital, LMU Munich, particularly for oligometastases where patients with 81377 München, Germany limited metastatic disease are still considered curable. moritz.wildgruber@ med.uni- Response assessment of those minimally invasive muenchen.de therapies is nevertheless limited. Traditional imaging Prof. S. Nahum Goldberg criteria, such as the response evaluation criteria in solid Department of Radiology, tumors (RECIST), frequently fail to assess, in a timely Hadassah Hebrew University manner, the effect of minimally invasive cancer treatment. Medical Center, Ein Karem, Jerusalem 91120, Israel Liquid biopsies (i.e., blood analyses) can greatly supplement response assessment by non-invasively [email protected] providing very specific biomarkers of tumor biology and its spread, or response to treatment. The role of biomarkers to gauge the response to minimally invasive tumor Deadline for manuscript treatments is the primary topic of this Special Issue. submissions: 30 June 2022 mdpi.com/si/65445 SpeciaIslsue IMPACT FACTOR 6.639 an Open Access Journal by MDPI Editor-in-Chief Message from the Editor-in-Chief Prof.
    [Show full text]
  • A Cross Sectional Study of Retraction Notices of Scholarly Journals of Science
    DESIDOC Journal of Library & Information Technology, Vol. 39, No. 2, March 2019, pp. 74-81, DOI : 10.14429/djlit.39.2.14000 2019, DESIDOC A Cross Sectional Study of Retraction Notices of Scholarly Journals of Science Manorama Tripathi#,*, Sharad Kumar Sonkar$, and Sunil Kumar^ #Dr B R Ambedkar Central Library, Jawaharlal Nehru University, New Delhi - 110 067, India $Department of Library and Information Science, Babasaheb Bhimrao Ambedkar University, Lucknow - 226 025, India ^Planning & Development Division, Indira Gandhi National Open University, New Delhi - 110 068, India *E-mail: [email protected] ABSTRACT Retraction is the withdrawal of published article after it is found that the authors did not ensure integrity in conducting and reporting their research activities. The bibliometric information of 4716 document categorised as retractions in Science Citation Index, Web of Science was downloaded and analysed to understand trend, pattern and reasons of retraction. The results showed that retractions had increased during the ten-year period, 2008-2017. The main reasons for retractions were plagiarism, falsified data, manipulation of images and figures. It was also found that just 40 out of 4716 retraction notices had explicitly stated reasons for retracting the published articles. The open access journals had more number of retractions as compared to subscription based journals. The study will guide library professionals and research scholars towards a better comprehension of the reasons behind retractions in science discipline in the ten-year period. They would be better equipped to steer clear of inauthentic publications in their citations and references. Keywords: Retraction; Misconduct; Scholarly journal 1. INTRODUCTION substantial overlap, use of falsified or fabricated data, adoption The scholarly journals are prime channels of extensive of unethical norms or procedures during research activities or communication of research findings to the world.
    [Show full text]
  • Scholarly Publishing Symposium Yinting Zhang Streaming.Docx
    00:00:00 Moderator: Hello. Welcome to the second part of our symposium. My name is Elizabeth Sosnowska and I'm Head of Collection Development for the Health Sciences Libraries. I am responsible for the selection and the assessment of all of health sciences resources including scholarly journals, databases and all the other electronic and print content. It is 00:00:30 my great pleasure to introduce our next speaker, my colleague and friend Yinging Zhang, who is the Research Services Librarian at the Robert Wood Johnson Library in New Brunswick. Ying is not only an experienced librarian and a frequent lecturer, but also an expert in research metrics and citation management tools, such as EndNote and Mendeley. She routinely consults with faculty on research and publishing practices and teaches sessions in 00:01:00 numerous curriculum-based courses. Ying is also the author of many scholarly publications, research guides EndNote tutorials. She currently serves as Chair of the library's Research and Scholar Environmental Working Group. Welcome Ying. YINTING ZHANG: Thank you. Thank you Ella. Good afternoon everyone. It is a great opportunity to share with you the librarian's perspectives on scholarly publishing. As 00:01:30 George mentioned in his presentation, the volume of scholarly articles being published at an accelerating speed. We all are aware that more and more journal articles are being published. I think because of the Internet and Open Access. Without the Internet, Open 00:02:00 Access would not even be possible. In the next fifteen (15) minutes I will be covering a very brief overview of the differences between traditional and Open Access scholarly publishing, and I will show you how to select reputable journals, what kind of sets of criteria to use to assess journals, and how to avoid predatory journals.
    [Show full text]
  • BIOCHIMICA ET BIOPHYSICA ACTA - GENERAL SUBJECTS One of the 10 Topical Journals of BBA
    BIOCHIMICA ET BIOPHYSICA ACTA - GENERAL SUBJECTS One of the 10 topical journals of BBA AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Audience p.1 • Impact Factor p.1 • Abstracting and Indexing p.2 • Editorial Board p.2 • Guide for Authors p.5 ISSN: 0304-4165 DESCRIPTION . BBA General Subjects accepts for submission either original, hypothesis-driven studies or reviews covering subjects in biochemistry and biophysics that have general scientific interest for a wide audience. Interdisciplinary studies are encouraged. Descriptive studies without biochemical or biophysical mechanistic evidence and insights are discouraged. Preferred topics are: biomedicine: fundamental and emerging topics in biochemistry/biophysics with potential medical implications nanobiology/nanotechnology: nanoparticles, nanotoxicology, nanomedicine omics: genomics, proteomics, lipidomics, glycomics, bioinformatics experimentally addressing a defined biological question chemical biology: chemical compounds, drug mechanisms, synthesis of novel compounds, click chemistry structural biology: crystallography, NMR, multimeric proteins, protein dynamics, nucleic acids novel complexes: nucleic acids, pure natural compounds, synthetic compounds, protein complexes, nucleic acid derivatives cellular signaling: receptor signaling, protein phosphorylation cascades, phosphatases, secondary messengers, transcription regulation, gene expression glycobiology: sugar metabolites and metabolism, glycosylated proteins, membrane protein, glycosylation, glycomics redox
    [Show full text]
  • Web of Science Use in Published Research and Review Papers 1997–2017: a Selective, Dynamic, Cross-Domain, Content-Based Analysis
    Scientometrics https://doi.org/10.1007/s11192-017-2622-5 Web of Science use in published research and review papers 1997–2017: a selective, dynamic, cross-domain, content-based analysis 1 2 1 Kai Li • Jason Rollins • Erjia Yan Received: 5 December 2017 Ó The Author(s) 2017. This article is an open access publication Abstract Clarivate Analytics’s Web of Science (WoS) is the world’s leading scientific citation search and analytical information platform. It is used as both a research tool supporting a broad array of scientific tasks across diverse knowledge domains as well as a dataset for large-scale data-intensive studies. WoS has been used in thousands of published academic studies over the past 20 years. It is also the most enduring commercial legacy of Eugene Garfield. Despite the central position WoS holds in contemporary research, the quantitative impact of WoS has not been previously examined by rigorous scientific studies. To better understand how this key piece of Eugene Garfield’s heritage has con- tributed to science, we investigated the ways in which WoS (and associated products and features) is mentioned in a sample of 19,478 English-language research and review papers published between 1997 and 2017, as indexed in WoS databases. We offered descriptive analyses of the distribution of the papers across countries, institutions and knowledge domains. We also used natural language processingtechniques to identify the verbs and nouns in the abstracts of these papers that are grammatically connected to WoS-related phrases. This is the first study to empirically investigate the documentation of the use of the WoS platform in published academic papers in both scientometric and linguistic terms.
    [Show full text]